New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
07:11 EDTCICigna price target raised to $71 from $62 at Jefferies
Jefferies raised its price target for Cigna following the company's Q4 results and keeps a Buy rating on the stock.
News For CI From The Last 14 Days
Check below for free stories on CI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2014
11:31 EDTCIAetna rises after topping expectations, raising guidance
Shares of healthcare insurer Aetna (AET) are advancing after its first quarter results topped analysts' consensus estimates and it raised its fiscal 2014 outlook. WHAT'S NEW: This morning, Aetna reported Q1 adjusted earnings per share of $1.98 and revenue of $13.99B, topping expectations of $1.56 and $13.72B, respectively. Medical membership in Q1 increased to over 22.7M, a sequential increase of 529,000 members. Aetna is targeting year-end medical membership of more than 23M, an increase of 800,000-1M members for the year. “Aetna posted higher operating earnings, operating revenues and medical membership in the first quarter, each representing historic highs for our company...This performance is once again a testament to the strength of our diversified portfolio, continued progress in integrating the Coventry acquisition, pricing discipline and solid execution. Our strong membership growth in the quarter came from both our commercial and government businesses, and we project this momentum will continue,” said Mark Bertolini, Aetna chairman, CEO and president. WHAT'S NOTABLE: The company raised its FY14 EPS view to $6.35-$6.55 from at least $6.25, versus consensus of $6.38. It also raised its FY14 revenue outlook to $56B-$57B from at least $54B, compared to consensus of $54.89B. PRICE ACTION: In late morning trading, Aetna rose $3.61, or 5.2%, to $72.52 on heavy trading volume. Including today's advance, the stock up about 27% over the past twelve months. OTHERS TO WATCH: Other companies in the healthcare benefits space include UnitedHealth Group (UNH), Cigna (CI), WellPoint (WLP) and Humana (HUM), all of which are higher on the session.
April 15, 2014
06:32 EDTCIPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use